JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PEACH, M. J.
Right arrow Articles by KHAIRALLAH, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PEACH, M. J.
Right arrow Articles by KHAIRALLAH, P. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*METARAMINOL
*TRITIUM
Journal of Pharmacology And Experimental Therapeutics, Vol. 167, Issue 2, 291-299, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF NOREPINEPHRINE UPTAKE IN HEARTS BY ANGIOTENSIN II AND ANALOGS

MICHAEL J. PEACH 1, F. MERLIN BUMPUS 1, and PHILIP A. KHAIRALLAH 1

1 Research Division, Cleveland Clinic, Cleveland, Ohio

Isolated rabbit hearts were perfused for 2 hr with Krebs' solution at 37°C, pH 7.3 to 7.35 and flow rates of 8 to 12 ml/min. H3-norepinephrine (H3NE), 10 ng/ml, was added to the perfusate, and the hearts were perfused for 15 min. The amount of H3NE accumulated in the heart was determined in the right auricle and left ventricle by scintillation counting. Total myocardial NE was determined fluorometrically. Angiotensin II (02 ng/ml) and angiotensin amide (2.0, 0.2 and 0.05 ng/ml) inhibited the uptake of H3NE. Addition of blood to the perfusate decreased the amount of inhibition obtained with peptide administration. When significant inhibition of uptake occurred, there was a potentiation of the positive chronotropic response to NE. Angiotensin also inhibited the uptake of H3-metaraminol. Several analogs of angiotensin were studied in an attempt to determine thestructural requirements needed for uptake inhibition in the heart. In general, changes in positions 1 to 7 showed good correlation between inhibition of H3NE uptake and pressor activity. However, a similar correlation was not found with peptides substituted in position 8. These analogs had pressor activities ranging from 0.1 to 10% but produced marked inhibition of H3NE accumulation. These results suggest that angiotensin receptors on sympathetic nerve endings have different structural requirements than do muscle receptors and that levels of the peptide close to normal circulating plasma levels have the ability to modulate NE inactivation by uptake processes.

Submitted on October 10, 1968
Accepted on February 13, 1969




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Apparsundaram, S. Schroeter, E. Giovanetti, and R. D. Blakely
Acute Regulation of Norepinephrine Transport: II. PKC-Modulated Surface Expression of Human Norepinephrine Transporter Proteins
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 744 - 751.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.